Abstract:Cerebral small vessel disease (SVD) causes lacunar stroke and intracerebral hemorrhage, and is the most common pathology underlying vascular cognitive impairment. Increasingly, the importance of other clinical features of SVD is being recognized including motor impairment, (vascular) parkinsonism, impaired balance, falls, and behavioral symptoms, such as depression, apathy, and personality change. Epidemiological data show a high prevalence of the characteristic magnetic resonance imaging (MRI) features of white matter hyperintensities and lacunar infarcts in community studies, and recent data suggest that it is also a major health burden in low- and middle-income countries. In this review, we cover advances in diagnosis, imaging, clinical presentations, pathogenesis, and treatment.The two most common pathologies underlying SVD are arteriolosclerosis caused by aging, hypertension, and other conventional vascular risk factors, and cerebral amyloid angiopathy (CAA) caused by vascular deposition of β-amyloid. We discuss the revised Boston criteria of CAA based on MRI features, which have been recently validated. Imaging is providing important insights into pathogenesis, including improved detection of tissue damage using diffusion tensor imaging (DTI) leading to its use to monitor progression and surrogate endpoints in clinical trials. Advanced MRI techniques can demonstrate functional or dynamic abnormalities of the blood vessels, while the high spatial resolution provided by ultrahigh field MRI at 7 T allows imaging of individual perforating arteries for the first time, and the measurement of flow velocity and pulsatility within these arteries. DTI and structural network analysis have highlighted the importance of network disruption in mediating the effect of different SVD pathologies in causing a number of symptoms, including cognitive impairment, apathy, and gait disturbance.Despite the public health importance of SVD, there are few proven treatments. We review the evidence for primary prevention, and recent data showing how intensive blood pressure lowering reduces white matter hyperintensities (WMH) progression and delays the onset of cognitive impairment. There are few treatments for secondary prevention, but a number of trials are currently evaluating novel treatment approaches. Recent advances have implicated molecular processes related to endothelial dysfunction, nitric oxide synthesis, blood-brain barrier integrity, maintenance and repair of the extracellular matrix, and inflammation. Novel treatment approaches are being developed to a number of these targets. Finally, we highlight the importance of large International collaborative initiatives in SVD to address important research questions and cover a number which have recently been established.

Neuroimaging Diagnostic Criteria and Standardized Definition of Terms for Small Vessel Disease in China—Expert Consensus from the Chinese Stroke Association

Neuroimaging standards for research into small vessel disease—advances since 2013

New standard of neuroimaging markers of cerebral small vessel disease

Cerebral small vessel disease: neuroimaging markers and clinical implication

Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease

Correlation Study Between Small Vessel Disease and Early Neurological Deterioration in Patients with Mild/moderate Acute Ischemic Stroke

Diffusion tensor imaging in cerebral small vessel disease applications: opportunities and challenges

Progress in Research of Cerebral Small Vessel Disease and Cerebral Microcirculation

Cerebral Small Vessel Disease and Vascular Cognitive Impairment: Focus on Neuroimaging

Advance in early recognition and magnetic resonance imaging diagnosis of cerebral small vessel disease

Cerebral small vessel disease: Recent advances and future directions

Consensus statement for diagnosis of subcortical small vessel disease

A Development History of Cerebral Small Vessel Disease

Update on cerebral small vessel disease: a dynamic whole-brain disease

Imaging, biomarkers, and vascular cognitive impairment in China: Rationale and design for the VICA study

Advances in Biomarkers of Cerebral Small Vessel Disease

Imaging, Genetic, and Pathological Features of Vascular Dementia

Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment

The Altered Reconfiguration Pattern of Brain Modular Architecture Regulates Cognitive Function in Cerebral Small Vessel Disease

Altered Spontaneous Brain Activity Related to Neurologic Dysfunction in Patients With Cerebral Small Vessel Disease

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study